Delivery Order SPE2DB20D9153-SPE2DB25FF21S
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,115.65 by the Defense Logistics Agency on July 21, 2025, for the supply of Jakafi 10 mg tablets (60-count packages). The contract utilizes a firm fixed-price structure with no set-aside designation and carries an ultimate completion date of July 22, 2025. This delivery order is issued under DMS Pharmaceutical Group's existing single-award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, valued at $12,115.65, is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which carries a total contract value of $499,999,999 through...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $48.6K on August 14, 2025, for the supply of Jakafi 5 mg tablets (60-count units) to support federal medical supply needs. This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, represents execution under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,115.65 for Jakafi 10 mg tablets (60-count units) by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. This delivery order was issued without a set-aside designation, and performance will take place at the vendor's Park Ridge, Illinois facility. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on July 28, 2025, by the Defense Logistics Agency (DLA) for the supply of Jakafi 15 mg tablets (60 count). This $24.0K firm fixed-price delivery order, which was completed on July 29, 2025, carries no set-aside designation and represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $72,880.74 on August 11, 2025, for the supply of Jakafi 5 mg tablets (60-count units). The award was issued under a firm fixed-price contract with no set-aside designation and is set for ultimate completion by August 12, 2025. The contract is funded by the Defense Logistics Agency's Medical Supply Chain division and will be performed at the...
- The Defense Logistics Agency awarded a $24,231.30 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 60 tablets of Jakafi 10 mg on August 22, 2025, with an ultimate completion date of August 25, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12.0K on July 22, 2025, for the supply of Jakafi 15 mg tablets (60-count units). This firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), the Department of Defense's combat support agency responsible for logistics and supply chain management. The award carries an ultimate completion date of July 23, 2025, and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $24,231.30 for 60 tablets of Jakafi 10 mg on July 18, 2025. The contract, which has no set-aside designation, is set to be completed by July 21, 2025, with performance at the awardee's Park Ridge location. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $48.6K by the Defense Logistics Agency on August 18, 2025, for the supply of Jakafi 5 mg tablets (60-count units). This firm fixed-price delivery order, which carries an ultimate completion date of August 19, 2025, represents a discrete purchase under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at...
- SPE2DB20D9153Indefinite Delivery Contract
- SPE2DB20D9153-SPE2DB25FF21SDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 25, 2025, valued at $48.4K by the Defense Logistics Agency for 60 tablets of Jakafi 20 mg. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a single supply fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The award carries no set-aside designation, allowing the company to compete on open market terms. Jakafi (ruxolitinib) is a prescription medication used to treat myeloproliferative neoplasms and other conditions, making this a specialized pharmaceutical supply supporting federal healthcare operations. This delivery order falls under DMS Pharmaceutical Group's significant $500M indefinite delivery contract with the Defense Logistics Agency's SPE2DB program, valid through November 2026. The broader contract enables the DLA to issue firm fixed-price delivery orders for comprehensive pharmaceutical supplies supporting military health facilities worldwide, encompassing branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables. As a consistent supplier to the Department of Defense healthcare system, DMS Pharmaceutical Group has established itself as a critical vendor in the federal pharmaceutical supply chain, leveraging its woman-owned small business status to serve the military's ongoing medication and medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48.4k | 8/25/25 |